The FDA has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

(HealthDay News) — Mindfulness (MI) and transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex offer therapeutic benefit for reducing situational urgency urinary ...

(HealthDay News) — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.

(HealthDay News) — A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5 in the European Journal of ...

Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.

A phase 2 trial of patients receiving hemodialysis via an arteriovenous graft found no benefit from a factor XI inhibitor. The monoclonal antibody MK-2060 does not meaningfully lower arteriovenous ...